No profile data available.
Beyond Air, Inc. (XAIR) is a healthcare company in the targeted healthcare equipment industry, based in Garden City, United States, with about 54 full-time employees.
It reported revenue of $7.68 million for fiscal year 2026, up 107.3% from fiscal year 2025, and net income of -$33.25 million. In Q1 2027 (the quarter ended June 30, 2026) revenue was $1.77 million, up 0.5% from a year before. Its market capitalization was $2.21 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn.
Beyond Air reported $7.68 million in revenue for fiscal year 2026, up 107.3% from $3.71 million in fiscal year 2025. In Q1 2027 revenue was $1.77 million.
$2.21 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Deltagen Inc. (DGEN), REMSleep Holdings, Inc. (RMSL), Vycor Medical, Inc. (VYCO), Escalon Medical Corp. (ESMC).